Patent details

EP1265629 Title: USE OF GROWTH HORMONE IN LOW DOSE

Basic Information

Publication number:
EP1265629
PCT Application Number:
PCT/SE/2001/000522
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019142892
PCT Publication Number:
WO/2001/068127
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF GROWTH HORMONE IN LOW DOSE
French Title of Invention:
UTILISATION DE L'HORMONE DE CROISSANCE A FAIBLE DOSE
German Title of Invention:
VERWENDUNG VON WACHSTUMSHORMON IN NIEDEREN DOSEN
SPC Number:

Dates

Filing date:
13/03/2001
Grant date:
07/06/2006
EP Publication Date:
07/06/2006
PCT Publication Date:
20/09/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/12/2002
EP B1 Publication Date:
07/06/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/03/2009
Expiration date:
13/03/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/03/2001
 
 

Name:
Pfizer Health AB
Address:
-, 112 87 Stockholm, Sweden (SE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
21/06/2006
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
DUNGER David B., c/o Dept. of Paediatrics
Address:
United Kingdom (GB)

Priority

Priority Number:
0000837
Priority Date:
13/03/2000
Priority Country:
Sweden (SE)

Classification

Main IPC Class:
A61K 38/27;
Filing date Document type Number of pages